A recombinant derivative of the human tumor necrosis factor (hTNF), a structural gene coding for the recombinant derivative, expression vector, host cells transformed E. coli, methods of making the recombinant derivative and the structural gene, oligonucleotide for use in the manufacture of the gene therapeutic compositions and formulations